Reactive Arthritis

Top Story

Cancer, infection risk higher among patients treated with IL inhibitors

Cancer, infection risk higher among patients treated with IL inhibitors
October 29, 2019
Feature

When Autoimmune Disease Strikes Thrice: Managing Multiple Autoimmune Syndrome

September 20, 2019
By the time Lilly Stairs was diagnosed with psoriatic arthritis at the age of 19 — following an arduous series of tests and doctor visits — she had already…
Feature

Social media opens new avenue to advocacy in rheumatology

June 21, 2019
Political activism is more accessible than ever thanks to the amplification offered by social media, and rheumatologists can use social media — particularly…
Q&A With Healio Rheumatology

Speaking the Language: Health care execs join United Rheumatology to advocate for independent practice

May 24, 2019
In the ever-changing landscape of the United States health care system, rheumatologists need a voice. They need a voice in managing the complex web of drug pricing…
More Headlines »
CME ABIM MOC

Ace the Case: A 78-Year-Old Man With Acute Onset of Right Ankle Pain and Swelling

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the diagnosis and management of a 78-year-old man…
More »
Video
Meeting News Coverage

VIDEO: Silverman discusses immunology links between cancer treatments and rheumatic diseases

March 15, 2016
More »
CME ABIM MOC

3rd Annual Association of Women in Rheumatology National Conference: Immunology Bootcamp - Best Of!

This activity is supported by educational grants from AbbVie, Inc.; Amgen Inc.; Bristol-Myers Squibb; Genentech, Inc.; GlaxoSmithKline; Lilly USA, LLC; Merck & Co., Inc.; and Sanofi Genzyme and Regeneron Pharmaceuticals.

Immune-mediated inflammatory diseases (IMIDs) are a group of clinically heterogeneous disorders, including rheumatoid…
More »